Achilles Therapeutics Gets 180-Day Extension After Nasdaq Market Transfer
Achilles Therapeutics has received approval to transfer its listing from the Nasdaq Global Market to...
Therapeutics
Achilles Therapeutics Receives Approval to Transfer to
LONDON, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Achilles Therapeutics plc (NASDAQ: ACHL) today announced that on November 15, 2024, the...
Affinia Therapeutics Appoints Rami Daoud as Chief Business and Financial Officer
Rami Daoud, M.B.A. Affinia Therapeutics, an innovative company with a proprietary platform pioneering a shift to a new class of...
Affinia Therapeutics Names New Chief Business & Financial Officer
Affinia Therapeutics, an innovative company with a proprietary platform pioneering a shift to a new class of rationally-designed gene therapies...
